TFEB and Parkinson disease: STAT3 and TFEB signaling increased with HPgV titer in PD-WT but decreased in PD-LRRK2, consistent with prior reports that LRRK2 mutations, particularly G2019S, influence STAT3-mediated immune regulation and TFEB-driven lysosomal function (55, 56).